Art. 4 Free trade Agreement between the European Union and its Member States, of the one part,…

Ethical business practices

In forcesince 1 Jan 2023
1.

Each Party shall adopt or maintain appropriate measures to prohibit improper inducements by manufacturers and suppliers of pharmaceutical products or medical devices to health care professionals or institutions for the listing, purchasing or prescribing of pharmaceutical products and medical devices eligible for reimbursement under health care programmes.

2.

Each Party shall adopt or maintain appropriate penalties and procedures to enforce the measures that it adopts or maintains in conformity with paragraph 1.

3.

Each Party shall bring to the other Party’s attention any improper inducements conducted by its manufacturers of pharmaceutical products or medical devices. The Parties recall their obligations under the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions which entered into force on 15 February 1999.

  1. 1 Jan 2023 – todayin force
  2. 1 Aug 2018 – 1 Jul 2021earlier wording

Versions are held from 6 Oct 2010; the article may be older.